chitosan and plga microspheres as drug delivery ... - UniCA Eprints

More documents

Recommendations

Info

4. RFP Loaded Chitosan Microspheres Prepared by Precipitation Method1001008080% RFP released6040% RFP released6040202000 20 40 60 80time (hours)00 20 40 60 80Time (hours)Form. 1 Form. 2 Form. 3Form. 4 Form. 5 Form. 6Form. 1 Form. 2 Form. 3Form. 4 Form. 5 Form. 6Figure 4.7: Release Studies pH 4.4 Figure 4.8: Release Studies pH 7.41008060% RFP402000 20 40 60Time (hours)Form. 1Form.2Form.3 Form. 4Form. 5 Form. 6Figure 4.9: Release Studies pH 1.266
4. RFP Loaded Chitosan Microspheres Prepared by Precipitation MethodStability of chitosan microspheres at pH 1.2 was also evaluated by studying the drug release.As can be seen in figure 4.9, the release in this acidic medium is even faster than that obtainedat pH 4.4. Obviously, this is related to the highly acidic release medium that caused the higherionization of the D-glucosamine residues with a resulting faster and higher swelling degree,and a very fast release of the drug. As it is evident from the graph, a strong burst effect wasfound with from 22.3 to 41.5% of RFP released in the first 2 hrs of the experiments. However,also in this case the crosslinking with GA led a decrease of the drug release rate.4.2.7. Mucoadhesive StudiesAdvantages of mucoadhesive properties of particles for inhalation therapy are a cause ofargue among scientists. In fact, considering the meaning of mucoadhesion and taking intoaccount the lung mucociliary clearance it could seems a disadvantage. However, it is wellknown that the mucociliary clearance is more important in the upper airways while particulateadhesion to the mucus layer of the lungs can activate macrophage activity. Finally, it is alsoimportant to underline that chitosan exerts a transient inhibitory effect on mucociliaryclearance of the bioadhesive formulations due to its surface charge, molecular contact andflexibility, and this is a further advantage for the delivery of RFP to the lungs and in particularto macrophages where the MTB and MAC are able to replicate.Since a strong interaction exists between mucin and chitosan, mucin should be spontaneouslyadsorbed to the surface of the chitosan microspheres. For this reason, the mucoadhesivebehaviour of chitosan microspheres was assessed by suspending chitosan microspheres indifferent amounts of mucin aqueous solutions at room temperature. As can be seen in figure4.10 the amount of mucin adsorbed increased by increasing mucin concentration. Theseresults confirmed that chitosan microspheres have the ability to adsorb mucin. No statisticallydifference could be observed in the capability to adsorb mucin between uncross- and crosslinkedmicrospheres (Figure 4.10) although a higher mean value of adsorbed mucin wasalways obtained from the uncross-linked microspheres. The adsorption of mucin to chitosan isexpected to be dominated by the electrostatic attraction between positively charged chitosanand negatively charged mucin (the negative charge of mucin is due to the ionization of sialicacid). Therefore, surface charge of chitosan microspheres represented by zeta potential wouldinfluenced the amount absorbed. For all the batches the amount of adsorbed mucin decreasedwith decreasing in zeta potential.67
Page 1:
European Union Ministero dell’Uni
Page 5 and 6:
Table Of Contents1. GENERAL INTRODU
Page 7:
7.1.4. Release Studies/Stability St
Page 10 and 11:
1. General Introduction1.1. Pulmona
Page 12 and 13:
1. General Introductionmucosa, and
Page 14 and 15:
1. General Introductionis the fact
Page 16 and 17: 1.3. Lung Anatomy1. General Introdu
Page 18 and 19: 1. General Introductionhighly vascu
Page 20 and 21: 201. General Introductionliquid (84
Page 22 and 23: 1. General IntroductionAerosol size
Page 24 and 25: 1. General Introductionof numerous
Page 26 and 27: 1. General Introductionintermittent
Page 28 and 29: 1. General Introductionsphere prepa
Page 30 and 31: 1. General Introductionit, respecti
Page 32 and 33: 1. General Introductionthe subject
Page 34 and 35: 1. General IntroductionA. zahoor et
Page 36 and 37: 2. Chitosan And PLGA2.1. Chitosan a
Page 38 and 39: 2. Chitosan And PLGAfor the prepara
Page 40 and 41: 2. Chitosan And PLGAmainly controll
Page 42 and 43: 2. Chitosan And PLGAAt present, a n
Page 44 and 45: 2. Chitosan And PLGAneed to be a go
Page 46 and 47: 2. Chitosan And PLGAdichloromethane
Page 49 and 50: 3. Aim of the Work49
Page 51: 3. Aim of the WorkBiodegradable mic
Page 54 and 55: 4. RFP Loaded Chitosan Microspheres
Page 71 and 72: 5. Rifampicin Loaded ChitosanMicros
Page 83: 5. RFP Loaded Chitosan Microspheres
Page 86 and 87: 6. RFP Loaded PLGA Microspheres Pre
Page 100 and 101: 100
Page 102 and 103: 7. RFP Loaded PLGA Coated Chitosan
Page 116 and 117:
7. RFP Loaded PLGA Coated Chitosan
Page 118 and 119:
118
Page 120 and 121:
8. Final Discussion and Conclusions
Page 122 and 123:
9. References9. References1. Fred S
Page 124 and 125:
9. References40. Wayne L.G., Good R
Page 126 and 127:
1269. References88. Carpenter R.L.
Page 128 and 129:
1289. References135. Fukushima S.;
Page 130 and 131:
9. References173. Zeng X.M., Martin
Page 132 and 133:
9. References219. Berthold A., Crem
Page 134:
9. Referencesmediates target gene e
show all

chitosan and plga microspheres as drug delivery ... - UniCA Eprints

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?